Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
PURPOSE: This study aimed to give a nationwide comprehensive picture of the prevalence and prescription patterns of benzodiazepines (BZ) and Z-drugs (ZD) in Switzerland and to analyze the association with adverse health care outcomes. PATIENTS AND METHODS: A population-based, cross-sectional study was conducted, using a large health insurance database in Switzerland. Records from all adult patients with ≥1 prescription for a benzodiazepine and/or a Z-drug in 2018 were included. We calculated the prevalence of BZ and ZD user (extrapolated to the Swiss general population), the number of prescriptions and the type of provider (among each BZ and ZD only user). Multivariate logistic regression models were performed to estimate the association between drug prescription and the risk of hospitalization in different healthcare settings. RESULTS: Of a total of 844'692 patients, 95'179 had ≥1 BZ and/or ZD prescription in 2018. The extrapolated one-year prevalence for the general Swiss population was 8.1% for a BZ prescription, 3.5% for a ZD prescription, and 10.5% for a BZ and/or ZD prescription, and continuously increased with age. The majority of the elderly (over 65 years) had ≥1 prescription (BZ: 51.9%; ZD: 56.9%; BZ and/or ZD: 53.5). The proportion of patients with ≥6 prescriptions per year was 23.1% for BZ only user and 35.2% for ZD only user. Most patients had ≥1 prescription from a general practitioner. Regression models showed a higher likelihood to be admitted to acute care, psychiatry, rehabilitation, or nursing home with ≥1 prescription for a benzodiazepine and/or a Z-drug. CONCLUSION: This study is the first to give a nationwide overview of the current use of benzodiazepines and Z-drugs in Switzerland based on health insurance claims data. The results revealed a remarkably high prevalence among the general Swiss population, especially in older generations. The negative consequences of heavy BZ and ZD use are a crucial public health problem, that should be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 2018, between 8.3% and 12.8% of BZD users in Switzerland have prescriptions from multiple physicians which resulted in the inability to track the number of prescriptions a patient is given yearly [40].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15767 · Cited by 3,163
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
European guideline for the diagnosis and treatment of insomnia
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., Espie, C. A., Garcia‐Borreguero, D., Gjerstad, M., Gonçalves, M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12594 · Cited by 2,049 · cited 1×
“9 In the treatment of anxiety disorders, benzodiazepines are important due to their fast onset of action, but are usually a second-line option and used as short-term or additional therapy.”
BackgroundPotentially Inappropriate Medications in the Elderly
Holt, S., Schmiedl, S., & Thürmann, P. A. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0543 · Cited by 791 · cited 2×
“This finding is of critical importance, especially when considering the classification of benzodiazepines and Z-drugs as potentially inappropriate medication in the elderly on the PRISCUS List (an overview of unsuitable medications in older age groups and recommendations for alternatives), due to an increased risk of…”
BackgroundBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Anxiety disorders in older adults: a comprehensive review
Wolitzky-Taylor, K. B., Castriotta, N., Lenze, E. J., Stanley, M. A., & Craske, M. G. (2010) · Depression and Anxiety · doi:10.1002/da.20653 · Cited by 726 · cited 1×
“The lowering likelihood for psychiatric hospitalization in the elderly can partly be explained by the finding that the prevalence of anxiety disorders declines with older age compared to younger age groups.(65)”
BackgroundBenzodiazepine use and risk of Alzheimer's disease: case-control study
Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., & Begaud, B. (2014) · BMJ · doi:10.1136/bmj.g5205 · Cited by 558
Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996–2013
Bachhuber, M. A., Hennessy, S., Cunningham, C. O., & Starrels, J. L. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303061 · Cited by 531
Benzodiazepine use and risk of dementia: prospective population based study
Billioti de Gage, S., Begaud, B., Bazin, F., Verdoux, H., Dartigues, J.-F., Peres, K., Kurth, T., & Pariente, A. (2012) · BMJ · doi:10.1136/bmj.e6231 · Cited by 436
Review of Safety and Efficacy of Sleep Medicines in Older Adults
Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.010 · Cited by 373 · cited 1×
“26,27 Furthermore, hospital patients who were prescribed benzodiazepines during their stay had a higher likelihood to have more bed days in the hospital.”
BackgroundBenzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies
Markota, M., Rummans, T. A., Bostwick, J. M., & Lapid, M. I. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.07.024 · Cited by 307
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
Lader, M. H. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00051-6 · Cited by 220 · cited 1×
“Benzodiazepines and Z-drugs are primarily prescribed for the treatment of insomnia, with benzodiazepines additionally being used for the treatment of anxiety.(2,3) Benzodiazepines and Z-drugs are some of the most frequently prescribed drugs in several health care systems, although their continued use is not supported…”
BackgroundIslam, M. M., Iqbal, U., Walther, B., Atique, S., Dubey, N. K., Nguyen, P.-A., Poly, T. N., Masud, J. H. B., Li, Y.-C. (., & Shabbir, S.-A. (2016) · Neuroepidemiology · doi:10.1159/000454881 · Cited by 218 · cited 1×
“25 There is also a higher risk to be hospitalized for fall-related injuries after taking benzodiazepines or Z-drugs among elderly people.”
BackgroundHuber, C. A., Szucs, T. D., Rapold, R., & Reich, O. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1030 · Cited by 213 · cited 1×
“Twenty-two comorbid chronic conditions were classified.(32) To calculate the proportion of patients with a single chronic condition in 2018, we divided the number of patients with at least one ATC-group defined medication prescription by all insured persons of the study.”
BackgroundSelf-citationSafety of benzodiazepines in the geriatric population
Madhusoodanan, S., & Bogunovic, O. J. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.5.485 · Cited by 195 · cited 1×
“52 This qualifies long-acting benzodiazepines as a potentially inappropriate medication in the elderly.”
BackgroundPhysicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study
Cook, J. M., Marshall, R., Masci, C., & Coyne, J. C. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0021-3 · Cited by 178 · cited 1×
“49,50 Furthermore, general practitioners reported insufficient knowledge and confidence in the provision and use of alternative psychological therapies in the management of insomnia.”
BackgroundWu, C., Wang, S.-C., Chang, I., & Lin, K. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181a65210 · Cited by 166
Emerging drugs for the treatment of anxiety
Murrough, J. W., Yaqubi, S., Sayed, S., & Charney, D. S. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1049996 · Cited by 164 · cited 1×
“10 Both national and international recommendations like the updated “AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults” or the “Choosing wisely Switzerland” campaign even postulate that benzodiazepine and Z-drug use should be avoided, especially in the elderly.”
BackgroundPatterns and correlates of benzodiazepine use in the French general population
Lagnaoui, R., Depont, F., Fourrier, A., Abouelfath, A., B�gaud, B., Verdoux, H., & Moore, N. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0808-2 · Cited by 160
Fourrier, A., Letenneur, L., Dartigues, J., Moore, N., & Bégaud, B. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100326 · Cited by 158 · cited 1×
“–41 This higher prevalence of use for women can be partly explained by the association of poor sleep and insomnia with menopause.”
BackgroundThe Epidemiology of Long-Term Benzodiazepine Use
Neutel, C. I. (2005) · International Review of Psychiatry · doi:10.1080/09540260500071863 · Cited by 148 · cited 2×
“7,8,35,45,46 We assume that the guidelines are very challenging to implement and insufficiently practicable in their current form.”
BackgroundFinkle, W. D., Der, J. S., Greenland, S., Adams, J. L., Ridgeway, G., Blaschke, T., Wang, Z., Dell, R. M., & VanRiper, K. B. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03591.x · Cited by 140
Petitjean, S., Ladewig, D., Meier, C. R., Amrein, R., & Wiesbeck, G. A. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328105e0f2 · Cited by 132 · cited 1×
“Our findings of the remarkable high prevalence of drug use are comparable with previous research.(11,14,15) International studies showed a prevalence between 2.”
ResultGPs’ management strategies for patients with insomnia: A survey and qualitative interview study
Everitt, H., McDermott, L., Leydon, G., Yules, H., Baldwin, D., & Little, P. (2014) · British Journal of General Practice · doi:10.3399/bjgp14x677176 · Cited by 127 · cited 1×
“Furthermore, general practitioners reported insufficient knowledge and confidence in the provision and use of alternative psychological therapies in the management of insomnia.(51) Due to changes in pharmacokinetics and pharmacodynamics resulting from older age, the risk of benzodiazepine side effects increases in the…”
BackgroundBierman, E. J. M., Comijs, H. C., Gundy, C. M., Sonnenberg, C., Jonker, C., & Beekman, A. T. F. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1811 · Cited by 114
Imfeld, P., Bodmer, M., Jick, S. S., & Meier, C. R. (2015) · Drug Safety · doi:10.1007/s40264-015-0319-3 · Cited by 112
Egan, M., Moride, Y., Wolfson, C., & Monette, J. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04758.x · Cited by 109 · cited 1×
“7,8,35,45,46 We assume that the guidelines are very challenging to implement and insufficiently practicable in their current form.”
BackgroundCook, J. M., Biyanova, T., Masci, C., & Coyne, J. C. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0205-5 · Cited by 107 · cited 1×
“49,50 Furthermore, general practitioners reported insufficient knowledge and confidence in the provision and use of alternative psychological therapies in the management of insomnia.”
BackgroundSidorchuk, A., Isomura, K., Molero, Y., Hellner, C., Lichtenstein, P., Chang, Z., Franck, J., de la Cruz, L. F., & Mataix‐Cols, D. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002635 · Cited by 102 · cited 1×
“The most common diagnoses were anxiety and depression.(64) The lowering likelihood for psychiatric hospitalization in the elderly can partly be explained by the finding that the prevalence of anxiety disorders declines with older age compared to younger age groups.”
BackgroundTen-year trends in benzodiazepine use in the Dutch population
Sonnenberg, C. M., Bierman, E. J. M., Deeg, D. J. H., Comijs, H. C., van Tilburg, W., & Beekman, A. T. F. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-011-0344-1 · Cited by 100
Yu, N.-W., Chen, P.-J., Tsai, H.-J., Huang, C.-W., Chiu, Y.-W., Tsay, W.-I., Hsu, J., & Chang, C.-M. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0530-4 · Cited by 97 · cited 1×
“There is also a higher risk to be hospitalized for fall-related injuries after taking benzodiazepines or Z-drugs among elderly people.(26,27) Furthermore, hospital patients who were prescribed benzodiazepines during their stay had a higher likelihood to have more bed days in the hospital.”
BackgroundKroll, D. S., Nieva, H. R., Barsky, A. J., & Linder, J. A. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3740-0 · Cited by 94 · cited 1×
“53,54 In a Swiss study analyzing emergency department presentations for symptoms consistent with acute toxicity, the most frequently reported drugs were benzodiazepines.”
BackgroundAnxiolytic, hypnotic and sedative medication use in Australia
Hollingworth, S. A., & Siskind, D. J. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1899 · Cited by 92 · cited 1×
“Benzodiazepines and Z-drugs are primarily prescribed for the treatment of insomnia, with benzodiazepines additionally being used for the treatment of anxiety.(2,3) Benzodiazepines and Z-drugs are some of the most frequently prescribed drugs in several health care systems, although their continued use is not supported…”
BackgroundLuta, X., Bagnoud, C., Lambiris, M., Decollogny, A., Eggli, Y., Le Pogam, M.-A., Marques-Vidal, P., & Marti, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-031156 · Cited by 73 · cited 6×
“7,8 14–20 For example, one study, which was based on claims data from the elderly (≥65 years), showed that approximately 20% had at least one benzodiazepine prescription.”
BackgroundInfluentialFrey, D. J., Ortega, J. D., Wiseman, C., Farley, C. T., & Wright, K. P. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03229.x · Cited by 64
Biétry, F. A.-M., Pfeil, A. M., Reich, O., Schwenkglenks, M. M., & Meier, C. R. (2017) · CNS Drugs · doi:10.1007/s40263-016-0404-x · Cited by 62
Long-term use of zolpidem increases the risk of major injury: a population-based cohort study
Lai, M.-M., Lin, C.-C., Lin, C.-C., Liu, C.-S., Li, T.-C., & Kao, C.-H. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.01.021 · Cited by 58
Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data
Gomm, W., von Holt, K., Thomé, F., Broich, K., Maier, W., Weckbecker, K., Fink, A., Doblhammer, G., & Haenisch, B. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151006 · Cited by 55
Provider Patient-Sharing Networks and Multiple-Provider Prescribing of Benzodiazepines
Ong, M.-S., Olson, K. L., Cami, A., Liu, C., Tian, F., Selvam, N., & Mandl, K. D. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3470-8 · Cited by 49 · cited 1×
“47,48 Additionally, we found that the largest proportion of users received only one prescription, but the second-largest group, interestingly, was the group with ≥6 prescriptions with a prevalence of 23.1% to 35.2%.”
BackgroundInfluentialPréville, M., Bossé, C., Vasiliadis, H.-M., Voyer, P., Laurier, C., Berbiche, D., Pérodeau, G., Grenier, S., Béland, S.-G., Dionne, P.-A., et al. (2012) · Canadian Journal on Aging / La Revue canadienne du vieillissement · doi:10.1017/s0714980812000232 · Cited by 47 · cited 1×
“Our prevalence finding is lower than in the previous international research, where around one-quarter had a prescription for a long-acting benzodiazepine agent.(11,13) A recent study found a prevalence of 25% for long-acting agents, 67.”
ResultHypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians
Kassam, A., & Patten, S. B. (2006) · Population Health Metrics · doi:10.1186/1478-7954-4-15 · Cited by 44
Nowakowski, S., Meliska, C. J., Martinez, L. F., & Parry, B. L. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0025-6 · Cited by 43 · cited 1×
“42 This correlates with our finding of a remarkable prevalence difference for men and women around perimenopausal age.”
BackgroundAlvarenga, J. M., Filho, A. I. D. L., Firmo, J. O. A., Lima‐Costa, M. F., & Uchôa, E. (2009) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2009000300015 · Cited by 42 · cited 1×
“Previous research also found that benzodiazepine recipients were higher users of medical care, had more emergency department visits, and were hospitalized more frequently.(53,54) In a Swiss study analyzing emergency department presentations for symptoms consistent with acute toxicity, the most frequently reported drug…”
BackgroundLong-term use of benzodiazepines in older patients in Germany: a retrospective analysis
Jacob, L., Rapp, M. A., & Kostev, K. (2017) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317696454 · Cited by 41 · cited 2×
“7,8,35,45,46 We assume that the guidelines are very challenging to implement and insufficiently practicable in their current form.”
BackgroundResultInfluentialSusukida, R., Mojtabai, R., & Mendelson, T. (2015) · Depression and Anxiety · doi:10.1002/da.22366 · Cited by 40 · cited 1×
“43 We found that the main prescription provider was a general practitioner, which is consistent with previous research.”
ResultTrends in the prescription of benzodiazepines for the elderly in Korea
Hwang, S.-H., Han, S. J., Choi, H.-J., Park, C.-S., Kim, S. M., & Kim, T. H. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1467-z · Cited by 40 · cited 1×
“2,3 4–8 European guidelines for the diagnosis and treatment of insomnia recommend the use of benzodiazepines and Z-drugs only as effective short-term treatments of insomnia ( 4 weeks), if cognitive behavioral therapy is not sufficient or available (first-line treatment).”
BackgroundINTERFERENCE WITH THE RECONSOLIDATION OF TRAUMA-RELATED MEMORIES IN ADULTS
Kredlow, M. A., & Otto, M. W. (2015) · Depression and Anxiety · doi:10.1002/da.22343 · Cited by 39
Use of benzodiazepines in the treatment of anxiety.
Cascade, E. F., & Kalali, A. H. (2008) · Europe PMC (PubMed Central) · Cited by 38
Benzodiazepine prescription and length of hospital stay at a Japanese university hospital
Nakao, M., Sato, M., Nomura, K., & Yano, E. (2009) · BioPsychoSocial Medicine · doi:10.1186/1751-0759-3-10 · Cited by 21 · cited 1×
“28 There is very little research about the association of benzodiazepine use and adverse health care outcome in Switzerland.”
BackgroundTardelli, V. S., Fidalgo, T. M., Santaella-Tenorio, J., & Martins, S. S. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107573 · Cited by 21
Doctor Shopping: A Concept Analysis
Worley, J., & Hall, J. M. (2012) · Research and theory for nursing practice · doi:10.1891/1541-6577.26.4.262 · Cited by 17 · cited 1×
“47,48 Additionally, we found that the largest proportion of users received only one prescription, but the second-largest group, interestingly, was the group with ≥6 prescriptions with a prevalence of 23.1% to 35.2%.”
BackgroundInfluentialUsages et mésusages des benzodiazépines chez les patients souffrant de troubles psychiatriques
Panes, A., Fourrier‐Réglat, A., Verdoux, H., & Tournier, M. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.10.003 · Cited by 17
Benzodiazepine und Z-Substanzen – Analyse der kassenärztlichen Verschreibungen von 2006 bis 2015
Verthein, U., Buth, S., Holzbach, R., Neumann-Runde, E., & Martens, M. (2019) · Psychiatrische Praxis · doi:10.1055/a-0961-2371 · Cited by 16
Scholz, I., Schmid, Y., Exadaktylos, A. K., Haschke, M., Liechti, M. E., & Liakoni, E. (2019) · Swiss Medical Weekly · doi:10.4414/smw.2019.20056 · Cited by 15 · cited 1×
“55 62 The likelihood for hospitalization in a psychiatric facility was especially high among the youngest age group (18–24 years) and decreased within older age groups.”
BackgroundLi, C., Santaella-Tenorio, J., Mauro, P. M., & Martins, S. S. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.04.029 · Cited by 14 · cited 1×
“5,11,12 Among adults aged 65 years and older, a Swiss study including data from nine of the 26 cantons of Switzerland found a prevalence of about 20% of users with at least one prescription for a benzodiazepine, with a higher prevalence for women than men.”
BackgroundThe Frequency of Benzodiazepine Use in the Isparta Province
Akpınar, A., Yaman, A., Karakus, K., Atay, İ. M., & Demirci, K. (2016) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20150707103818 · Cited by 10 · cited 1×
“5% in the general population.(5,11,12) Among adults aged 65 years and older, a Swiss study including data from nine of the 26 cantons of Switzerland found a prevalence of about 20% of users with at least one prescription for a benzodiazepine, with a higher prevalence for women than men.”
BackgroundUsages et mésusages des benzodiazépines chez les patients souffrant de troubles psychiatriques
Panes, A., Fourrier‐Réglat, A., Verdoux, H., & Tournier, M. (2018) · French Journal of Psychiatry · doi:10.1016/s2590-2415(19)30442-8 · Cited by 9
Psychological and social approaches to treatment
Henshaw, C. A. (2008) · Psychiatry · doi:10.1016/j.mppsy.2008.10.011 · Cited by 6
Research works printed but not linked: 2
- Mihic SJ, Mayfield J, Harris RA. Hypnotics and sedatives. In: Brunton LL, Hilal-Dandan R, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 13 ed. McGraw-Hill Education; 2017.
- Donato F, Samani F, Marini M, et al. Across-sectional survey on benzodiazepine use among older people in an Italian region. Ital J Public Health. 2005; 2.
Cited by
Benzodiazepines: Uses, Dangers, and Clinical Considerations
Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021) · Neurology International · doi:10.3390/neurolint13040059 · Cited by 340
“8% of BZD users in Switzerland have prescriptions from multiple physicians which resulted in the inability to track the number of prescriptions a patient is given yearly [40].”
BackgroundLong-term use of benzodiazepines in chronic insomnia: a European perspective
Soyka, M., Wild, I., Caulet, B., Leontiou, C., Lugoboni, F., & Hajak, G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1212028 · Cited by 121
“BZDs can be categorized as short-acting [half-life (T1/2) <24 h] and long-acting treatment (T1/2 > 24 h) (72).”
Barbaux, L., Perrault, A. A., Cross, N. E., Weiner, O. M., Essounni, M., Pomares, F. B., Tarelli, L., McCarthy, M., Maltezos, A., Smith, D., et al. (2025) · SLEEP · doi:10.1093/sleep/zsaf168 · Cited by 34
A Need for Benzodiazepine Deprescribing in the COVID-19 Pandemic: A Cohort Study
Bužančić, I., Pejaković, T. I., & Hadžiabdić, M. O. (2022) · Pharmacy · doi:10.3390/pharmacy10050120 · Cited by 16
Representation of Benzodiazepines in Treatment Guidelines: The Paradox of Undesirable Objectivity
Starčević, V. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524772 · Cited by 12
Metadata
- Authors
- Landolt, S., Rosemann, T., Blozik, E., Brüngger, B., & Huber, C. A.
- Affiliations
- University of Zurich (CH)
- Helsana Group (Switzerland) (CH)
- Corresponding author
- Huber, Carola A
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2021-04
- Volume
- Volume 17
- Pages
- 1021-1034
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC8052118
- OpenAlex
- W3154783048
- Cited by
- 34
- References
- 58
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 1
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepines, Z-drugs, prescribing patterns, prevalence, hospitalization, older adults, general practitioners, health insurance claims data, Switzerland
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.